Thomas Feldthus

Member of the Board of Directors since 2018

Education: MSc in Engineering from the Technical University of Denmark (DTU), MSc in Management and Economics from the University of London, and a Fellow of the London Business School Sloan Program

Background: Previously, vVD, CFO and co-founder of Saniona; CFO and co-founder of Symphogen A/S

Other ongoing assignments: CEO at Saniona, Chairman of Rehaler ApS, Board member Synklino A/S and ResoTher Pharma ApS

Independence: Independent in relation to both the Company and executive management as well as larger shareholders

Scandion Oncology shares and warrants
28,182 shares (owned via Fertilizer Invest ApS) and 26,792 warrants